Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jin Ae Jun"'
Autor:
Jung Yeon Lim, Sang In Park, Seong Muk Kim, Jin Ae Jun, Ji Hyeon Oh, Chung Hun Ryu, Chang Hyun Jeong, Sun Hwa Park, Soon A. Park, Wonil Oh, Jong Wook Chang, Sin-Soo Jeun
Publikováno v:
Cell Transplantation, Vol 20 (2011)
The ability of mesenchymal stem cells (MSCs) to differentiate into neural cells makes them potential replacement therapeutic candidates in neurological diseases. Presently, overexpression of brain-derived neurotrophic factor (BDNF), which is crucial
Externí odkaz:
https://doaj.org/article/47088c971c4748feb81ff2131c7b5abe
Publikováno v:
Journal of Neuroimmunology. 274:20-27
We previously demonstrated that interferon β (IFN-β)-secreting mesenchymal stem cells (MSCs-IFN-β) strongly reduced the clinical severity of experimental autoimmune encephalomyelitis (EAE), compared with MSCs alone. Recently, minocycline ameliorat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e37ee57ec1c08bc73d7bae9531d25e0
https://doi.org/10.1016/j.jneuroim.2014.06.001
https://doi.org/10.1016/j.jneuroim.2014.06.001
Autor:
Sun Hwa Park, Soon A Park, Jung Yeon Lim, Seong Muk Kim, Jong Wook Chang, Wonil Oh, Chang Hyun Jeong, Sin-Soo Jeun, Chung Hun Ryu, Sang In Park, Ji Hyeon Oh, Jin Ae Jun
Publikováno v:
Cell Transplantation, Vol 20 (2011)
The ability of mesenchymal stem cells (MSCs) to differentiate into neural cells makes them potential replacement therapeutic candidates in neurological diseases. Presently, overexpression of brain-derived neurotrophic factor (BDNF), which is crucial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ec76eefe198bbbfa45994d07142f6c
https://doi.org/10.3727/096368910x557236
https://doi.org/10.3727/096368910x557236
Autor:
Chung Heon Ryu, Sun Hwa Park, Jin Ae Jun, Sin-Soo Jeun, Soon A Park, Wonil Oh, Seong Muk Kim, Ji Hyeon Oh, Jung Yeon Lim, Chang Hyun Jeong
Publikováno v:
Biochemical and Biophysical Research Communications. 398:105-110
Human mesenchymal stem cells (hMSCs) have been used for cell-based therapies in degenerative disease and as vehicles for delivering therapeutic genes to sites of injury and tumors. Recently, umbilical cord blood (UCB) was identified as a source for M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd6ece8a79ecb55676d0d40605adc51
https://doi.org/10.1016/j.bbrc.2010.06.043
https://doi.org/10.1016/j.bbrc.2010.06.043
Autor:
Jaekwon Lee, Jung Yeon Lim, Seong Muk Kim, Ji Hyeon Oh, Wonil Oh, Jin Ae Jun, Chang Hyun Jeong, Kwan-Sung Lee, Sin-Soo Jeun, Sang In Park
Publikováno v:
Journal of Neuroscience Research. 86:2168-2178
Brain-derived neurotrophic factor (BDNF) plays an important role in the differentiation, development, and survival of neural stem cells. In this study, we analyzed its effects on the stimulation of human umbilical cord blood-derived mesenchymal stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d72fd95c988711a031e4f588295093b
https://doi.org/10.1002/jnr.21669
https://doi.org/10.1002/jnr.21669
Publikováno v:
Cell Biology International.
The beneficial effects of mesenchymal stem cells (MSCs) are mediated partly by the paracrine production of cytoprotective and trophic factors. Vascular endothelial growth factor (VEGF) is released from MSCs as a paracrine trophic factor and contribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71caaf4aaf2a6f62c8f14848cad4012a
https://doi.org/10.1002/cbin.10294
https://doi.org/10.1002/cbin.10294
Publikováno v:
BioMed Research International, Vol 2014 (2014)
BIOMED RESEARCH INTERNATIONAL
BioMed Research International
BIOMED RESEARCH INTERNATIONAL
BioMed Research International
Numerous studies have reported that mesenchymal stem cells (MSCs) can ameliorate neurological deficits in ischemic stroke models. Among the various hypotheses that have been suggested to explain the therapeutic mechanism underlying these observations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8c394e0cd574538c9e8c99972ab070
https://doaj.org/article/a8af2e494be54c49b53c6b40803e21a1
https://doaj.org/article/a8af2e494be54c49b53c6b40803e21a1
Publikováno v:
Cell biology international. 38(9)
The beneficial effects of mesenchymal stem cells (MSCs) are mediated partly by the paracrine production of cytoprotective and trophic factors. Vascular endothelial growth factor (VEGF) is released from MSCs as a paracrine trophic factor and contribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6851be879f0ac9b1e7429c35e0189473
https://pubmed.ncbi.nlm.nih.gov/24797366
https://pubmed.ncbi.nlm.nih.gov/24797366
Autor:
Seong Muk Kim, Sin-Soo Jeun, Jung Yeon Lim, Won Il Oh, Jin Ae Jun, Chang Hyun Jeong, Sang In Park
Publikováno v:
Journal of Biomedicine and Biotechnology, Vol 2012 (2012)
Journal of Biomedicine and Biotechnology
Journal of Biomedicine and Biotechnology
Numerous studies have shown the benefits of mesenchymal stem cells (MSCs) on the repair of spinal cord injury (SCI) model and on behavioral improvement, but the underlying mechanisms remain unclear. In this study, to investigate possible mechanisms b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90073ab8daba563e2cecbac12e22ff65
Autor:
Yun Hou, Chang Hyun Jeong, Seong Muk Kim, Jin Ae Jun, Jong Wook Chang, Wonil Oh, Sin-Soo Jeun, Chung Heon Ryu, Jung Yeon Lim
Publikováno v:
Stem Cell Research & Therapy
Introduction Stem cell transplantation is a promising therapeutic strategy for the treatment of stroke. Mesenchymal stem cells (MSCs) are a potential cell source for clinical application because they can be easily obtained and cultivated with a high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b7a7ab7b71863a9b061eb3dc631284
https://doi.org/10.1186/scrt79
https://doi.org/10.1186/scrt79